Dec 3, 2012 | Digital Pathology, Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology
Innovative and inexpensive technologies hold the promise of instantaneous diagnosis while transforming conventional clinical laboratory tools
“Point-of-care pathology” may not be that far away! The convergence of medical and information technologies, the falling cost of computing, and the growing availability of miniaturization technologies make it increasingly possible for pathologists and physicians to make informed, on-the-spot diagnostic decisions about patient care.
A new wave of imaging technologies—including pathology tools—is poised to transform the practice of medicine, reported a recent story in the New York Times. Some of these technologies make it possible for pathologists and other physicians to view individual cells in situ and in vivo.
The NY Times story highlighted multiple research and development initiatives that have the same goal: reduce the time get an answer for tissue diagnosis and bring diagnostic tests to the patient. Some technologies would engage pathologists. Others reflect developments in radiology and imaging. (more…)
Apr 18, 2011 | Digital Pathology, Laboratory News, Laboratory Pathology
Interesting technology could be incorporated into medical laboratory tests
Though still in early development, “SmartPills” —a technology now being adapted for therapeutic drug delivery and monitoring—could be used in ways that bring pathologists into closer consultation with primary care physicians.
Using new drug-delivery technology created by California-based Proteus Biomedical, the SmartPill sends information from inside the patient’s body to a chip that’s worn outside on the skin in a patch, or embedded under the skin. The chip then uploads the data to a Smartphone or through the Internet to the prescribing physician.
(more…)
Jul 22, 2010 | Laboratory News, Laboratory Pathology
Goal is to deliver integrated digital pathology solutions to clinical pathology laboratories
Yesterday, Dako announced separate digital pathology agreements with Royal Philips Electronics (NYSE: PHG) and Omnyx, LLC. Both the Philips and Omnyx agreements give each company access to Dako’s proprietary software algorithms and reagents used in tissue analysis for certain cancers.
In the deal between Philips and Dako, Philips plans to incorporate certain of Dako’s image analysis applications to the digital pathology system it is currently developing. Breast cancer is the diagnostic area covered by this new agreement. Philips will get access to Dako’s image analysis software for tissue-based breast cancers diagnosis, in tandem with Dako’s reagents for staining HER2, Estrogen Receptor (ER), Progesterone Receptor (PR), p53 and Ki-67 proteins.
(more…)
